Artículos de revistas
Sclerostin And Insulin Resistance In Prediabetes: Evidence Of A Cross Talk Between Bone And Glucose Metabolism.
Registro en:
Diabetes Care. v. 38, n. 8, p. 1509-1517, 2015-Aug.
1935-5548
10.2337/dc14-2989
26084344
Autor
Daniele, Giuseppe
Winnier, Deidre
Mari, Andrea
Bruder, Jan
Fourcaudot, Marcel
Pengou, Zuo
Tripathy, Devjit
Jenkinson, Christopher
Folli, Franco
Institución
Resumen
A gene mutation of the Wnt/β-catenin signaling cascade is present in rare patients with the insulin resistance syndrome. Sclerostin is a circulating peptide inhibiting Wnt/β-catenin signaling. Our aims were to evaluate serum sclerostin in subjects with prediabetes and to analyze its relationship with insulin resistance and β-cell function. We performed a cross-sectional study including 43 healthy normal glucose-tolerant (NGT) individuals and 79 individuals with impaired glucose regulation (IGR), which included subjects with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and combined IFG-IGT, undergoing oral glucose tolerance test (OGTT) and dual-energy X-ray absorptiometry. A subgroup of 18 with NGT and 30 with IGR also underwent a euglycemic-hyperinsulinemic clamp with tracer. Sclerostin levels were higher in IGR compared with NGT (50.8 ± 2.4 vs. 38.7 ± 2.3 pmol/L; P = 0.01), positively correlated with HOMA-insulin resistance (IR) (r = 0.62; P < 0.001), and negatively correlated with insulin-mediated total body glucose disposal (r = -0.40; P < 0.001). Fasting endogenous glucose production (EGP) and hepatic and adipose tissue insulin resistance indexes were positively correlated with sclerostin levels (r = 0.48, r = 0.62, and r = 0.61, respectively; P < 0.001). Fasting and OGTT insulin clearance were inversely correlated with sclerostin serum levels (r = -0.52 and r = -0.44, respectively; both P < 0.001). Sclerostin levels were not correlated with β-cell function parameters. In multiple linear regression analysis, the addition of sclerostin levels to the traditional risk factors for insulin resistance improved the r(2) associated with HOMA-IR (r(2) change: 0.055; F change: 28.893; P = 0.001) and insulin-mediated total body glucose disposal (r(2) change: 0.059; F change: 4.938; P = 0.033). Sclerostin levels are increased in individuals with prediabetes and correlated with insulin resistance in skeletal muscle, liver, and adipose tissue. The correlation between sclerostin and insulin clearance at fasting state and during OGTT is novel; thus, studies are needed to explore the potential causal relationship. 38 1509-1517
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Daytime variations in glucose tolerance in people with impaired glucose tolerance
Santos, Maria Luiza dos; Aragon, Flávio F.; Padovani, Carlos R.; Pimenta, Walkyria P. -
Daytime variations in glucose tolerance in people with impaired glucose tolerance
Universidade Estadual Paulista (Unesp) (2006-12-01)To determine whether glucose tolerance varies throughout the day in people with impaired glucose tolerance (IGT). We studied 15 healthy IGT, and 18 matched normal glucose tolerant (NGT) individuals. Blood samples were taken ... -
Daytime variations in glucose tolerance in people with impaired glucose tolerance
Universidade Estadual Paulista (Unesp) (2006-12-01)To determine whether glucose tolerance varies throughout the day in people with impaired glucose tolerance (IGT). We studied 15 healthy IGT, and 18 matched normal glucose tolerant (NGT) individuals. Blood samples were taken ...